Glytec Awarded Patent Allowance Supporting Connected Care Model for Insulin Management
JANUARY 5, 2018 Glytec Awarded Patent Allowance Supporting Connected Care Model for Insulin Management The allowed patent encompasses detailed interactions between multiple connected diabetes technologies. Waltham, MA — Glytec, the pioneer of personalized digital therapeutics, has been awarded another U.S. patent allowance for systems and methods related to insulin management in the outpatient...
Read More